Sailong Pharmaceutical: Announcement on participating in the tenth batch of centralized national drug procurement and planning to win the bid
Sailong Pharmaceutical: Announcement on the subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Cailong Pharmaceutical: Announcement on the subsidiary obtaining a fluorouracil injection drug registration certificate
Cailong Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for esprolol hydrochloride injection
Sailong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining the “Notice of Approval of the Drug Supplement Application”
Sailong Pharmaceutical: Announcement on preparation for impairment calculation for the first three quarters of 2024
Sailong Pharmaceutical: Review Opinions of the Third Meeting of the Fourth Board Audit Committee in 2024
Sailong Pharmaceutical: Explanation of the Supervisory Board on the reasonableness of the company\'s impairment preparations
Sailong Pharmaceutical: Explanation of the Board of Directors and Audit Committee on the reasonableness of the company\'s impairment preparations
Cailong Pharmaceutical: Announcement on the Election of the Chairman of the Supervisory Board
Sailong Pharmaceutical: Legal Opinion on the 2024 Fourth Extraordinary General Meeting of Shareholders of Sailong Pharmaceutical Group Co., Ltd.
Cailong Pharmaceutical: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
Sailong Pharmaceutical: Announcement on completing the by-election of non-employee representative supervisors of the 4th board of supervisors
Sailong Pharmaceutical: Announcement on Subsidiaries Obtaining Approval Notice for Chemical Raw Material Marketing Applications
Sailong Pharmaceutical: Announcement on the progress of the “Headquarters Project Cooperation Agreement” and its supplementary agreement
Sailong Pharmaceutical: Announcement on Subsidiaries Obtaining Approval Notice for Chemical Raw Material Marketing Applications
Sailong Pharmaceutical: Announcement on the Resignation of the Company\'s Supervisor and the By-election of Non-Employee Representative Supervisors
Sailong Pharmaceutical: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
Sailong Pharmaceutical: Legal Opinion of Beijing Kangda Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Sailong Pharmaceutical Group Co., Ltd.
Sailong Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
No Data